SW, S., KK, J., GL, G., MK, B., Ø, S., KH, B., . . . EA, H. (2021). Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial. JAMA, 326(23), 2375. https://doi.org/10.1001/jama.2021.21316
Chicago Style (17th ed.) CitationSW, Syversen, et al. "Effect of Therapeutic Drug Monitoring Vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial." JAMA 326, no. 23 (2021): 2375. https://doi.org/10.1001/jama.2021.21316.
MLA (9th ed.) CitationSW, Syversen, et al. "Effect of Therapeutic Drug Monitoring Vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial." JAMA, vol. 326, no. 23, 2021, p. 2375, https://doi.org/10.1001/jama.2021.21316.